Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2012 | 21 | 4 |
Tytuł artykułu

Non-specific cellular immunity in rabbits experimentally infected with four Czech strains of the rabbit haemorrhagic disease virus with different pathogenicity

Warianty tytułu
Języki publikacji
The rabbit haemorrhagic disease (RHD) virus was first described in 1984 in China, where it caused a rabbit plague characterized by an acute course. At present, the disease has spread to rabbits on all continents, and is characterized by morality reaching 100%. Research on the immune response in rabbits after infection by RHD virus strains has so far only been performed by the Deptuła team. In turn, it must be stated that similar research worldwide has been performed in the Chinese centre, yet referring exclusively to rabbits after immunization with inactivated RHD virus. Such research indicates that shortly after immunization, the immunity is coordinated by macrophages and lymphocytes T and B, while farther on the protection against the infection is conditioned by humoral immunity. Deptula's team has investigated 22 strains of RHDV in the aspect of non-specific cellular and humoral immunity, as well as specific cellular and humoral immunity including 3 French strains (FR-1, Fr-2, 9905RHDVa), 10 Polish strains (K-l, Kr-1, KGM, SGM, MAŁ, BLA, PD, GSK, Ż, ŻD), 4 German strains (Hagenow, Frankfurt, Triptis, Hartmannsdorf), 3 Italian strains (BS89-reference strain, Vt97, PV97), 1 English strain (Rainham), and 1 Spanish strain (Asturias). The strains were analyzed in the aspect of such parameters as capacity of adherence and absorption of PMN cells, PMN cell cidal property measured with spontaneous, stimulated, and spectrophotometric NBT test, stimulation index and PMN metabolic activity coefficient; and MPO activity, as well as concentration and activity of LZM. Also, the number was marked of lymphocytes T CD5+, Th with receptor CD4+, Tc/Ts with receptor CD8+, and the number of lymphocytes with receptor CD25+, as well as the percentage of lymphocytes B (IgM). The research indicates the presence of immunogroups within the RHD virus. Assessment of pathogenicity of the RHD virus is actually performed based on the mortality rate in rabbits infected with the virus, which is dictated by the fact that the virus has so far not been obtained in vitro. Niedźwiedzka et al. divided the 10 analyzed strains into strains with high pathogenicity with mortality of 90-100%, up to 36/48 hour of the study (BS89, Hagenow, Rainham, Frankfart, Asturias, Triptis, Hartmannsdorf, Pv97, 9905RHDVa), and strains with lower pathogenicity with mortality of 30% up to 36/48h (Vt97). In turn, Tokarz-Deptuła divided the 10 analyzed strains of the RHDV (including 8 Polish and 2 French) into strains with mortality of 80-100% (Fr-2, ŻD, GSK, SGM, Fr-1, Kr-1, MAL), strains with mortality of 60-65% (KGM, BLA), and strains with mortality below 60% (PD). The aim of our study was to record changes to parameters of non-specific cellular immunity (capacity of adherence and absorption of PMN cells, cidal capacity of PMN cells measured with spontaneous NBT test, stimulated and spectrophotometric, and stimulation index and metabolic activity ratio of PMN cells) in rabbits experimentally infected with 4 haemagglutinogenic Czech strains of the RHD virus: CAMPV-351 (reference strain), CAMP-561, CAMPV-562, and CAMPV-558, with different pathogenicity; which strains have not yet been analyzed in this respect. The assessment of pathogenicity of the analyzed strains of the RHDV was performed on the basis of mortality rate among rabbits infected with these strains. On the basis of the number and duration of changes to analyzed parameters of non-specific cellular immunity, the 4 analyzed Czech strains are determined to differentiate in the aspect of immunogenicity into three groups. The first group is formed by the most immunogenic reference strain CAMPV-351, the second - by two medium-immunogenic strains - CAMPV-561 and CAMPV-558, whereas the third one - by the least immunogenic strain CAMPV- 562. The results obtained in the area of pathogenicity are not reflected in the division of the analyzed Czech strains according to their immunogenicity.
Opis fizyczny
  • Department of Microbiology and Immunology, Faculty of Biology, University of Szczecin, Felczaka 3c, 71-412 Szczecin, Poland
  • 1. TOKARZ-DEPTUŁA B. Immunity phenomena in rabbits infected with the RHD (rabbit haemorrhagic disease) virus. Pol. J. Environ. Stud. 7, 1, 2009.
  • 2. ANNON. Gen Bank National Center of Biotechnology Information, Pub Med. (date of last check 11.07.2011).
  • 3. GOULD A.R., KOTTENBELT J.A., LENGHAUS C., MORISSY C., CHALMBERLAIN T., COLLINS B.J., WESTBURY H.A. The complete nucleotide sequencing of rabbit haemorrhagic chain reaction to detected replication in Australian Vertebrates and analysis of viral population Sequence variation. Virus Res. 47, 7,1997.
  • 4. MEYERS G., WIRBLICH CH., THIEL H-J. Rabbit haemorrhagic disease virus- molecular cloning and nucleotide sequencung of a calicivirus genome. Virology 184, 664, 1991.
  • 5. CAPUCCI L., FALLACARAE, GRAZIOLIS., LAVAZZA A., LODOVICA PACCIARINI M., BROCCHI E. A further step in the evolution of rabbit hemorrhagic disease virus: the appearance of the first consistent antigenic variant. Virus Res. 58, 115,1998.
  • 6. RASSCHAERT D., HUGUET S„ MADELAINE M-F., VAUTHEROT J-F. Sequence and genomic organization of a rabbit haemorrhagic disease virus isolated from a wild rabbit. Virus Genes. 9, 121, 1994.
  • 7. PARRA F., BOGA J.A., MARIN M.S., CASAIS R. Molecular cloning, sequencing and expression in Escherichia coli of the capsid protein gene from rabbit haemorrhagic disease virus (Spanish isolate AST/89). J. Gen. Virol. 75, 2409,1994.
  • 8. MCINTOSH M.T., BEHAN S.C., MOHAMED F.M., LU Z„ MORAN K.E, BURRAGE T.G, NEILAN J.G, WARD G.B, BOTTI G., CAPUCCI L., METWALLY S.A. A pandemic strain of calcivirus threatens rabbit industries in the Americas. Virol. J. 4, 96, 2007.
  • 9. CAPUCCI L., CHASEY D., LAVAZZA A., WESTCOTT D. Preliminary chracterization of a non-haemagglutinating strain of rabbit haemorrhagic disease virus from the United Kingdom. J. Vet. Med. B 43, 245,1996.
  • 10. KĘSY A., FITZNER A., NIEDBALSKI W., PAPROCKA G., WALKOWIAK B. A new variant of the viral haemorrhagic disease of rabbits virus. Rev. sci. tech. Off. int. Epiz. 15, 1029,1996.
  • 11. PRIETO J. M., MARTIN J. M., ESPI A., PARRA F. A new non-haemagglutinating strain of rabbit haemorrhagic disease virus. In : Brocchi E., Lavazza A., (Ed.), Proceeding of 5th Int. Cong, of the Europ. Soc. Vet. Virol. "Veterinary Virology in the New Millenium," Brescia, Italy pp. 204, 2000.
  • 12. SCHIRRMEIER H. REIMANN I., KÖLLNER B., GRANZOW H. Pathogenic, antigenic and molecular properties of rabbit haemorrhagic disease virus (RHDV) isolated from vaccinated rabbits: detection and characterization of antigenic variants. Arch. Virol. 144, 419, 1999.
  • 13. LE GALL-RECULE G., ZWINGELSTEIN F., LAURENT S., DE BOISSÉSON C, PORTEJOIEY., RASSCHAERT D. Phylogenetic analysis of rabbit of rabbit haemorrhagic disease virus in France between 1993-2000, and characterization of RHDV antigenic variants. Arch Virol. 148, 65, 2003.
  • 14. TIAN L., LIAO J., LI J. W., ZHOU W. R., ZHANG X. L., WANG H. N. Isolation and identification of a non-haemagglutinating strain of rabbit hemorrhagic disease virus from China and sequence analysis for the VP60 gene. Virus Genes 35, 745, 2007.
  • 15. MARCHANDEAU S., LE GALL-RECULÉ G., BERTAGNOLI S. AUBINEAU J., BOTTI G., LAVAZZA A. Serological evidence for a non-protective RHDV-like virus. Vet. Res. 36, 53, 2005.
  • 16. MATIZ K, URSU K, KECSKEMETI S., BAJMOCY E., KISS I. Phylogenetic analysis of rabbit haemorrhagic disease virus (RHDV) strains isolated between 1988 and 2003 in eastern Hungary. Arch. Virol. 151, 1659, 2006.
  • 17. FARNOS O., RODRIGUEZ D., VALDES O., CHIONG M., PARRA F., TOLEDO J. R., FERNANDEZ E., LLEONART R. JUAREZ M. Molecular and antigenic characterization of rabbit hemorrhagic disease vims isolated in Cuba indicates a distinct antigenic subtype. Arch. Virol. 152, 1215, 2007.
  • 18. BILDTM. W. G., BOLHUIS G. H., ZIJDERVELD F., RIEL D., DREES J. M., OSTERHAUS A. D. M. E., KUIKEN T. Confirmation and phylogenetic analysis of rabbit hemorrhagic disease virus in free-living rabbits from the Netherlands. J. Wildlife Disease 42, 808, 2006.
  • 19. OEM J. K., LEE K. N., ROH I. S., LEE K. K, KIM H. R., PARK C. K., JOO Y. S. Identyfication and characterization of rabbit haemorrhagic disease virus genetic variants isolated in Korea. J. Vet. Med. Sci. 71, 1519, 2009.
  • 20. CHROBOCIŃSKA M., MIZAK B. Phylogenetic analysis of partial capsid protein gene of rabbit haemorrhagic disease virus (RHDV) strains isolated between 1993 and 2005 in Poland. Bull Vet Inst Puławy 51, 189, 2007.
  • 21. LE GALL-RECULE G., ZWINGELSTEIN F., BOUCHER S., LE NORMAND B., PLASSIART G., PORTEJOIE Y., DECORS A., BERTAGNOLI S., GUERIN J. L., MARCHANDEAU S. Detection of a new variant of rabbit haemorrhagic disease virus in France. Vet. Ree. 168, 137, 2011.
  • 22. NIEDŹWIEDZICA P. Immunological profile and apoptosis in rabbits experimentally infected with RHD (rabbit haemorrhagic disease) strains with different biological features. Doctoral thesis, University of Szczecin, Poland 2008 [In Polish],
  • 23. ABRANTES J., ESTEVES P.J., VAN DER LOO W. Evidence for recombination in the major capsid gene VP60 of the rabbit haemorrhagic disease virus (RHDV). Arch. Virol. 153, 329, 2008.
  • 24. FORRESTER N.L., MOSS S.R., TURNER S.L., SCHIRRMEIER H., GOULDE.A. Recombination in rabbit haemorrhagic disease virus: Possible impact on evolution and epidemiology. Virology 376, 390, 2008.
  • 25. ESTEVES P.J., ABRANTES J., CARNEIRO M., MÜLLER A., THOMPSON G., VAN DER LOO W. Detection of positive selection in the major capsid protein VP60 of the rabbit haemorrhagic disease virus (RHDV). Virus Res. 137,253, 2008.
  • 26. NYSTRÖM K, LE GALL-RECULE G., GRASSI P., ABRANTES J., RUVOÉN-CLOUET N., LE MOULLAC -VAIDYE B., LOPES A.M., ESTEVES P. J., STRIVE T., MARCHANDEAU S., DELL A., HASLAM S. M., LE PENDU J. Histo-blood group antigens act as attachment factors of rabbit hemorrhagic disease virus infection in a virus strain-dependent manner. PLoS Pathog 7, (8), 2011.
  • 27. STRIVE T., WRIGHT J.D., ROBINSON A.J. Identification and partial characterization of new lagovirus in Australian wild rabbits. Virology 384, 97, 2009.
  • 28. ABRANTES J., ESTEVES P.J. Not-so-novel Michigan rabbit calicivirus [letter]. Emerg Infect Dis 16, 1331, 2010.
  • 29. ANNON. Information and training materials of the Laboratory Animals Section, General Assembly of the Association of Agriculture Engineers and Technicians, In: Materiały informacyjno- szkoleniowe Sekcji ds. Zwierząt laboratoryjnych. ZG Stowarzyszenia Inżynierów i Techników Rolnictwa, Warsaw, Poland, pp. 26-77,1987 [In Polish],
  • 30. ANNON. Regulation of the Minister of Agriculture and Rural Development of 10 March 2006 on detailed conditions for manee of laboratory animals in experimental units, breeding units and suppliers (Pol. Journal of Laws of 2006, No. 50, item 368). 2006.
  • 31. LORENTE F., FONTAN G., GARCIA M.C.R., OJEDA J. A. A simple and reproducible method to evaluate granulocyte adherence. J. Immun. Meth. 19, 47,1973.
  • 32. DEPTUŁA W. Phagocytic activity of neutrophiles (PMN cells) in peripheral blood of bovine infected with (Bovid herpesvirus 1-BHV1). Pol. Arch. Wet. 31, 153,1991.
  • 33. PARK B.H., FIHRING S.M., SMITHOWICH E.M. Infection and nitroblue tetrazolium reduction by neutrophils A Diagnostic AID. Lancet 2, 532,1968.
  • 34. RAMAN U., POLAND R.L. A new microquantitive NBT test. Ped. Res. 9, 334, 1975.
  • 35. GRZĄDZIELSKA E.B. The study to evaluate the ability to phagocytosis of neutrophiles with the use of blue nitritetride reduction test. Doctoral thesis, Jagiellonian University, Krakow, Poland, 1976 [In Polish],
  • 36. LECHOWSKI A., LENARCIK M., DEGÓRSKI A., WINNICKA A. Serum lysozyme activity and nitroblue tetrazolium reduction test in dogs with diabetes mellitis. J. Vet. Med. A. 38, 530, 1991.
  • 37. NIEDŹWIEDZKA-RYSTWEJ P., DEPTUŁA W. Non-specific immunity in rabbits infected with 10 strain of the rabbit haemorrhagic disease vims with different biological properties. Centr. Europ. J. Biol. 5, 613, 2010.
  • 38. NIEDŹWIEDZKA-RYSTWEJ P., PAWLIKOWSKA M„ HUKOWSKA-SZEMATOWICZ B., TOKARZ-DEPTULA B., DEPTUŁA W. Immunological and genetic studies of RHD (rabbit haemorrhagic disease). Centr. Eur. J. Immunol. 34, 61, 2009.
  • 39. TOKARZ-DEPTULA B., ADAMIAK M., DEPTU£A T., PASTUSZAK-GABINOWSKA M., DEPTUŁA W. Nonspecific humoral immunity in rabbits experimentally infected with nine Polish strains of the RHD (rabbit haemorrhagic disease) virus. Adv. Agricult. Sci. 13, 133, 2010.
  • 40. NIEDŹWIEDZKA P., TOKARZ-DEPTUŁA B„ DEPTUŁA W. Ingestion capacity and haematological parameters in rabbits experimentally infected with strains of RHD (rabbit Haemorrhagic disease) virus differing in biological features. Adv. Agricult. Sci. 12, 99, 2008.
  • 41. DEPTUŁA W., KĘSY A., TOKARZ-DEPTUŁA B., STOSIK M., TRAVNICEK M. Dynamics of selected parameters in rabbits infected with rabbit haemorrhagic disease vims. Folia Veterinaria 43, 186,1999.
  • 42. TOKARZ-DEPTUŁA B., HUKOWSKA B., DEPTUŁA W. Dynamic alternations in selected indices of non specific immunity in rabbits experimentally infected with VHD (viral haemorrhagic disease) vims. Pol. J. Vet. Sci. 6, 70, 2003.
  • 43. TOKARZ-DEPTUŁA B., HUKOWSKA B., DEPTUŁA W. Ingestion capacity of PMN cells in peripheral blood of rabbits experimentally infected with VHD (viral haemorrhagic disease) vims strain originating from various biotopes. Pol. J. Vet. Sci. 6, 271,2003.
  • 44. PIEKARSKI J. The immunological and haematological picture and viral pathomorophogenesis and clinic investigations in rabbits experimentally infected with RHD (rabbit haemorrhagic disease) virus. Doctoral thesis, University of Warmia and Mazury, Olsztyn, Poland, 1994 [In Polish].
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.